During these unprecedented times, Clark, Perdue, & List Co, LPA is here to fully support your needs in a timely and safe manner. COVID-19 should not affect your ability to investigate a personal injury case. We currently remain open and are still accepting new cases. With your safety top of mind, we are scheduling all meetings via telephone or video conference at this time.

Proton Pump Inhibitors

Columbus Ohio Injury Attorneys Investigating Kidney Damage Caused by Proton Pump Inhibitors

We are investigating cases of chronic kidney disease and kidney failure in patients taking Proton Pump Inhibitors (PPI) found in popular stomach acid medications. Popular brand names of PPIs include Nexium, Protonix. Prilosec, and Prevacid. These medications are commonly used to treat heartburn and acid reflux.

In January 2016, a study showed a link between proton pump inhibitors and  chronic kidney disease. More recently, a second study published in the Journal of American Medical Association Internal Medicine, revealed that patients using PPis were 28% more likely to develop chronic kidney disease and  were at a 96% increased risk of developing kidney failure than patients who used other drugs to treat stomach acid symptoms. As many as 15 million Americans take proton pump inhibitors by prescriptions, and many more take PPIs in over-the-counter medication.

Chronic kidney disease entails a gradual loss of kidney function. The end result can be kidney failure, dialysis, kidney transplant, or even death. Common symptoms of kidney disease include:

  • Bone pain
  • Bad breath
  • Blood in the stool
  • Difficulty concentrating
  • Sleep disturbance
  • Excessive bruising
  • Excessive thirst
  • Fluid retention
  • Swelling of extremities
  • Appetite loss
  • Muscle twitching or cramps
  • Sexual dysfunction
  • Vomiting

Patients Who Suffer Kidney Damage Due to Heartburn Medication May Have a Claim

If you or a loved one has been diagnosed with chronic kidney disease or kidney failure and have a history of taking proton pump inhibitors, our Columbus Ohio pharmaceutical lawyers are available for free consultation.


E-Cigarette Companies Asking for An Extension from the FDA

Due to the recent coronavirus pandemic, e-cigarette makers are looking for an extension on their Food & Drug Administration (FDA) applications. A deadline of May 12, 2020 was previously set as a result of a lawsuit filed by the American Academy of Pediatrics.  The...

read more

FDA Proposes Recall of Zantac

The Food and Drug Administration has requested drug manufacturers recall the popular heart burn medication, Zantac. This move comes as a continuing FDA investigation has found that Zantac, and other drugs with the active ingredient ranitidine, often contain...

read more

Vaping and Smoking May Increase Your COVID-19 Risks

As the entire world struggles with the new realities of the coronavirus pandemic, much of the focus has been on higher-risk individuals contracting the virus.  Higher risk individuals include the elderly and people with compromised immune systems.  There is now...

read more

Vaping Deaths and Lung Injuries Continue to Rise

Deaths and Lung Injuries Continue to Rise From E-Cigarette and Vaping Use As of February 18, 2020, 68 deaths have been confirmed in 29 states due to the use of vaping products. Additionally, a total of 2,807 hospitalized e-cigarette, or vaping, product use-associated...

read more

Zantac Linked to Cancer Risk When Stored in High Heat

In a previous post, we wrote about the FDA's investigation into the heartburn medication, Zantac, and other drugs containing ranitidine. The problem is that ranitidine has been found to contain N-Nitrosodimethylamine (“NDMA”), a suspected cancer causing agent in...

read more